ストックスクリーナーアプリを入手
37.03
3.14%
-1.20
アフターアワーズ：
37.74
0.71
+1.92%
Harmony Biosciences Holdings Inc (HRMY) 最新ニュース
Medical Marijuana Clinical Trial Landscape Expands as 60+ Leading Companies Accelerate Drug Development | DelveInsight - GlobeNewswire Inc.
Why Harmony Biosciences Stock Got Mashed on Monday - The Motley Fool
Harmony Biosciences Announces Planned CEO Transition to Support Next Phase of Growth - Investing News Network
Harmony Biosciences Announces Planned CEO Transition to Support Next Phase of Growth - GlobeNewswire Inc.
HRMY vs. CSLLY: Which Stock Is the Better Value Option? - Zacks Investment Research
Is Harmony Biosciences (HRMY) Stock Undervalued Right Now? - Zacks Investment Research
Harmony Biosciences Holdings (NasdaqGM:HRMY) Stock Forecast & Analyst Predictions - Simply Wall Street
Harmony Biosciences Holdings, Inc. (HRMY) Stock Price, News, Quote & History - Yahoo! Finance Canada
Harmony Biosciences CMO sells $1.65m in shares By Investing.com - Investing.com South Africa
Harmony Biosciences CMO sells $1.65m in shares By Investing.com - Investing.com Australia
Harmony Biosciences CMO sells $1.65m in shares - Investing.com
Harmony Biosciences (HRMY) CMO exercises options and sells shares - Stock Titan
$1.5M stock sale planned by Harmony Biosciences (NASDAQ: HRMY) officer - Stock Titan
Harmony Biosciences Holdings Insider Sold Shares Worth $1,655,416, According to a Recent SEC Filing - Yahoo Finance
After preset plan trades, Harmony Biosciences (NASDAQ: HRMY) officer plans 800-share sale - Stock Titan
Harmony Biosciences Holdings, Inc.Common Stock (Nasdaq:HRMY) Price Chart - The Chronicle-Journal
Officer stock sale at Harmony Biosciences (NASDAQ: HRMY) follows earlier 10b5-1 trades - Stock Titan
(HRMY) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
HRMY: Pipeline expansion, BP-205 progress, and BD deals drive next phase of growth - TradingView
Engaging In Options Activity, Kumar Budur Exercises Options Valued At $262K In Harmony Biosciences Hldgs - Benzinga
Harmony Biosciences CMO Kumar Budur Executes Stock Sales and Option Exercises in Early September 2026 - Kalkine Media
Harmony Biosciences (NASDAQ: HRMY) CMO exercises 22,954 options, sells shares under trading plan - Stock Titan
Harmony Biosciences Holdings Insider Sold Shares Worth $1,453,169, According to a Recent SEC Filing - Yahoo Finance
Harmony Biosciences (NASDAQ: HRMY) officer lines up a seven-figure stock sale - Stock Titan
Here is Why Growth Investors Should Buy Harmony Biosciences (HRMY) Now - Eastern Progress
Harmony Biosciences stock holds near USD 41.86 - AD HOC NEWS
Harmony Biosciences (HRMY) executive to sell about $230K in stock - Stock Titan
Why Is Harmony Biosciences (HRMY) Up 12.1% Since Last Earnings Report? - Yahoo Finance
Harmony Biosciences to Present Encore EPX-100 Data from ARGUS Study at 16th European Epilepsy Congress - Quiver Quantitative
Harmony Biosciences Announces Poster Presentations at the 16th European Epilepsy Congress - Yahoo Finance
Harmony Biosciences stock hits 52-week high at $42.70 By Investing.com - Investing.com South Africa
Harmony Biosciences stock hits 52-week high at $42.70 By Investing.com - Investing.com Canada
Harmony Biosciences stock hits 52-week high at $42.70 By Investing.com - Investing.com India
Harmony Biosciences stock hits 52-week high at $42.70 - Investing.com
Precision Trading with Harmony Biosciences Holdings Inc. (HRMY) Risk Zones - Stock Traders Daily
Harmony Biosciences to Participate in 2026 Cantor Global Healthcare Conference - Investing News Network
This Atlassian Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday - Sahm
Harmony Biosciences to Participate in 2026 Cantor Global Healthcare Conference - GlobeNewswire
HRMY Initiates Coverage On Wolfe Research -- Rating Set to Outpe - GuruFocus
Wolfe Research initiates Harmony Biosciences stock at Outperform - Investing.com
Wolfe Research initiates Harmony Biosciences stock at Outperform By Investing.com - Investing.com Canada
Wolfe Research initiates Harmony Biosciences stock at Outperform By Investing.com - Investing.com UK
Virtus Advisers LLC Makes New Investment in Harmony Biosciences Holdings, Inc. $HRMY - MarketBeat
Tieton Capital Management LLC Takes Position in Harmony Biosciences Holdings, Inc. $HRMY - MarketBeat
Denali Advisors LLC Purchases 29,700 Shares of Harmony Biosciences Holdings, Inc. $HRMY - MarketBeat
Stephen M. Mollichella Net Worth (2026) - GuruFocus
Aurora Investment Counsel Invests $2.37 Million in Harmony Biosciences Holdings, Inc. $HRMY - MarketBeat
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Given Consensus Recommendation of "Hold" by Analysts - MarketBeat
Did Strong Q2 Earnings and Completed Buybacks Just Shift Harmony Biosciences' (HRMY) Investment Narrative? - simplywall.st
Did Strong Q2 Earnings and Completed Buybacks Just Shift Harmony Biosciences' (HRMY) Investment Narrative? - simplywall.st
6.42%
1.26%
大文字化:
|
ボリューム (24 時間):